BioSpace News Archive

Drug Development

Can Gilead Develop a Cure for HIV?

Gilead Sciences essentially created a cure for hepatitis C and may be well on its way to developing a cure for HIV-AIDS.

March 20, 2018
·
3 min read
·
Mark Terry
Drug Development

Ocugen’s Dry Eye Treatment Hit Its Primary Endpoint

Ocugen announced this morning that its mid-stage combination treatment hit its primary endpoint of tolerability in a proof-of-concept trial.

March 20, 2018
·
2 min read
·
Alex Keown
Drug Development

Arena Pharmaceuticals Shares Explode on Positive Ulcerative Colitis Trial Data

Arena Pharmaceuticals released positive top-line results from its Phase II trial of etrasimod in ulcerative colitis.

March 20, 2018
·
3 min read
·
Mark Terry
Drug Development

Genentech’s Tecentriq Shows Promise for First-line Lung Cancer Treatment

Tecentriq’s Phase III results gives Genentech a lead for potentially becoming the first-line treatment for squamous non-small cell lung cancer.

March 20, 2018
·
3 min read
·
Mark Terry
Drug Development

AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease

AstraZeneca’s drug Farxiga could receive a new indication for a subset of diabetes patients based on Phase III data that was released today.

March 20, 2018
·
2 min read
·
Alex Keown
FDA

FDA Grants Priority Review for Prostate Cancer Treatment

The FDA granted a Priority Review designation to Pfizer and partner Astellas Pharma for expanded use of Xtandi in prostate cancer treatment.

March 20, 2018
·
2 min read
·
Alex Keown
Career Advice

5 Ways to Position Yourself for a Promotion

Check out these five things you can do to before asking for a promotion.

March 20, 2018
·
3 min read
·
Porschia Parker
Business

Bicycle Therapeutics Promotes Michael Skynner, Ph.D., to Chief Operating Officer

Dr. Skynner has served as Bicycle’s Vice President of Operations and Discovery since January 2016.

March 20, 2018
·
3 min read
Genetown

Science Magazine Recognizes Frequency Therapeutics’ PCA Regeneration Technology as a Breakthrough in Regenerative Medicine

Frequency Co-founder Will McLean, Ph.D., Named a Finalist Awardee for the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy

March 20, 2018
·
3 min read
Biotech Bay

Varian-Equipped St. Petersburg Proton Therapy Center Completes First Patient Treatment

The patient was treated for a brain tumor at Russia’s first dedicated proton therapy treatment center.

March 20, 2018
·
2 min read